Reused skin grafts for treating hidradenitis suppurativa: A systematic review.
Reused skin grafts showed no surgical-site recurrences after excision for hidradenitis suppurativa.
Reused skin grafts for treating hidradenitis suppurativa: A systematic review.
Hidradenitis suppurativa (hidradenitis suppurativa) is a chronic, relapsing inflammatory disease in which wide excision remains the most reliable option for durable disease control in moderate to severe cases.
To systematically evaluate the outcomes of reused skin grafts following surgical excision of hidradenitis suppurativa, with emphasis on recurrence, graft take and procedure-related morbidity.
A PRISMA-compliant systematic review was conducted using PubMed, Web of Science and Google Scholar from inception to the final search date.
Sixteen studies met inclusion criteria, including five systematic reviews, two retrospective cohorts and nine case reports or small case series.
Complications were generally minor.
However, in the largest reused-graft series, which included 18 patients, 8 (44%) required supplemental conventional donor grafts.
Broader pooled estimates from conventional graft literature reported recurrence rates ranging from 2% to 18%, reflecting substantial heterogeneity.
Reused skin grafting appears feasible and safe in selected hidradenitis suppurativa patients, with encouraging short- to medium-term durability.
Current evidence supports feasibility rather than definitive comparative effectiveness, underscoring the need for well-designed prospective studies.